Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report

We report the first successful treatment with the IL-1 receptor antagonist anakinra, in association with the most promising and available antiviral therapy, of a severe case of novel coronavirus disease 2019 (COVID-19). We describe the diagnosis, clinical course, and management of the case, includin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Infect Dis
Päätekijät: Franzetti, Marco, Pozzetti, Ugo, Carugati, Manuela, Pandolfo, Alessandro, Molteni, Chiara, Faccioli, Paolo, Castaldo, Gioacchino, Longoni, Ernesto, Ormas, Valentina, Iemoli, Enrico, Piconi, Stefania
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7228890/
https://ncbi.nlm.nih.gov/pubmed/32422376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.05.050
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia